Hubbry Logo
ZoonosisZoonosisMain
Open search
Zoonosis
Community hub
Zoonosis
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Zoonosis
Zoonosis
Zoonosis
View on Wikipedia
from Wikipedia

A zoonosis (/zoʊˈɒnəsɪs, ˌzoʊəˈnoʊsɪs/ ⓘ;[1] plural zoonoses) or zoonotic disease is an infectious disease of humans caused by a pathogen (an infectious agent, such as a virus, bacterium, parasite, fungi, or prion) that can jump from a non-human vertebrate to a human. When humans infect non-humans, it is called reverse zoonosis or anthroponosis.[2][1][3][4]

Major modern diseases such as Ebola and salmonellosis are zoonoses. HIV was a zoonotic disease transmitted to humans in the early part of the 20th century, though it has now evolved into a separate human-only disease.[5][6][7] Human infection with animal influenza viruses is rare, as they do not transmit easily to or among humans.[8] However, avian and swine influenza viruses in particular possess high zoonotic potential,[9] and these occasionally recombine with human strains of the flu and can cause pandemics such as the 2009 swine flu.[10] Zoonoses can be caused by a range of disease pathogens such as emergent viruses, bacteria, fungi and parasites; of 1,415 pathogens known to infect humans, 61% were zoonotic.[11] Most human diseases originated in non-humans; however, only diseases that routinely involve non-human to human transmission, such as rabies, are considered direct zoonoses.[12]

Zoonoses have different modes of transmission. In direct zoonosis the disease is directly transmitted between non-humans and humans through the air (influenza), bites and saliva (rabies),[13] faecal-oral transmission or through contaminated food. Transmission can also occur via an intermediate species (referred to as a vector), which carry the disease pathogen without getting sick. The term is from Ancient Greek ζῷον (zoon) 'animal' and νόσος (nosos) 'sickness'.

Host genetics plays an important role in determining which non-human viruses will be able to make copies of themselves in the human body. Dangerous non-human viruses are those that require few mutations to begin replicating themselves in human cells. These viruses are dangerous since the required combinations of mutations might randomly arise in the natural reservoir.[14]

Causes

[edit]

The emergence of zoonotic diseases originated with the domestication of animals.[15][16] Zoonotic transmission can occur in any context in which there is contact with or consumption of animals, animal products, or animal derivatives. This can occur in a companionistic (pets)[16], economic (farming, trade, butchering, etc.), predatory (hunting, butchering, or consuming wild game), or research context.[17][18]

Recently, there has been a rise in frequency of appearance of new zoonotic diseases. "Approximately 1.67 million undescribed viruses are thought to exist in mammals and birds, up to half of which are estimated to have the potential to spill over into humans", says a study[19] led by researchers at the University of California, Davis. According to a report from the United Nations Environment Programme and International Livestock Research Institute a large part of the causes are environmental like climate change, unsustainable agriculture, exploitation of wildlife, and land use change. Others are linked to changes in human society such as an increase in mobility. The organizations propose a set of measures to stop the rise.[20][21]

Contamination of food or water supply

[edit]

Foodborne zoonotic diseases are caused by a variety of pathogens that can affect both humans and animals. The most significant zoonotic pathogens causing foodborne diseases are:

Bacterial pathogens

[edit]

Escherichia coli O157:H7, Campylobacter, Caliciviridae, and Salmonella.[22][23][24]

Viral pathogens

[edit]
  • Hepatitis E: Hepatitis E virus (HEV) is primarily transmitted through pork products, especially in developing countries with limited sanitation. The infection can lead to acute liver disease and is particularly dangerous for pregnant women.[25]
  • Norovirus: Often found in contaminated shellfish and fresh produce, norovirus is a leading cause of foodborne illness globally. It spreads easily and causes symptoms like vomiting, diarrhea, and stomach pain.[26]

Parasitic pathogens

[edit]
  • Toxoplasma gondii: This parasite is commonly found in undercooked meat, especially pork and lamb, and can cause toxoplasmosis. While typically mild, toxoplasmosis can be severe in immunocompromised individuals and pregnant women, potentially leading to complications.[27]
  • Trichinella spp. is transmitted through undercooked pork and wild game, causing trichinellosis. Symptoms range from mild gastrointestinal distress to severe muscle pain and, in rare cases, can be fatal.[28]

Farming, ranching and animal husbandry

[edit]
See also: Intensive animal farming § Human health impact

Contact with farm animals can lead to disease in farmers or others that come into contact with infected farm animals. Glanders primarily affects those who work closely with horses and donkeys. Close contact with cattle can lead to cutaneous anthrax infection, whereas inhalation anthrax infection is more common for workers in slaughterhouses, tanneries, and wool mills.[29] Close contact with sheep who have recently given birth can lead to infection with the bacterium Chlamydia psittaci, causing chlamydiosis (and enzootic abortion in pregnant women), as well as increase the risk of Q fever, toxoplasmosis, and listeriosis, in the pregnant or otherwise immunocompromised. Echinococcosis is caused by a tapeworm, which can spread from infected sheep by food or water contaminated by feces or wool. Avian influenza is common in chickens, and, while it is rare in humans, the main public health worry is that a strain of avian influenza will recombine with a human influenza virus and cause a pandemic like the 1918 Spanish flu.[30] In 2017, free-range chickens in the UK were temporarily ordered to remain inside due to the threat of avian influenza.[31] Cattle are an important reservoir of cryptosporidiosis,[32] which mainly affects the immunocompromised. Reports have shown mink can also become infected.[33] In Western countries, hepatitis E burden is largely dependent on exposure to animal products, and pork is a significant source of infection, in this respect.[25] Similarly, the human coronavirus OC43, the main cause of the common cold, can use the pig as a zoonotic reservoir,[34] constantly reinfecting the human population.

Veterinarians are exposed to unique occupational hazards when it comes to zoonotic disease. In the US, studies have highlighted an increased risk of injuries and lack of veterinary awareness of these hazards. Research has proved the importance for continued clinical veterinarian education on occupational risks associated with musculoskeletal injuries, animal bites, needle-sticks, and cuts.[35]

A July 2020 report by the United Nations Environment Programme stated that the increase in zoonotic pandemics is directly attributable to anthropogenic destruction of nature and the increased global demand for meat and that the industrial farming of pigs and chickens in particular will be a primary risk factor for the spillover of zoonotic diseases in the future.[36] Habitat loss of viral reservoir species has been identified as a significant source in at least one spillover event.[37]

Wildlife trade or animal attacks

[edit]

The wildlife trade may increase spillover risk because it directly increases the number of interactions across animal species, sometimes in small spaces.[38] The origin of the COVID-19 pandemic[39][40] is traced to the wet markets in China.[41][42][43][44]

Zoonotic disease emergence is demonstrably linked to the consumption of wildlife meat, exacerbated by human encroachment into natural habitats and amplified by the unsanitary conditions of wildlife markets.[45][46] These markets, where diverse species converge, facilitate the mixing and transmission of pathogens, including those responsible for outbreaks of HIV-1,[47] Ebola,[48] and mpox,[49] and potentially even the COVID-19 pandemic.[50] Notably, small mammals often harbor a vast array of zoonotic bacteria and viruses,[51] yet endemic bacterial transmission among wildlife remains largely unexplored. Therefore, accurately determining the pathogenic landscape of traded wildlife is crucial for guiding effective measures to combat zoonotic diseases and documenting the societal and environmental costs associated with this practice.

Insect vectors

[edit]

Pets

[edit]
Further information: Feline zoonosis

Pets can transmit a number of diseases. Dogs and cats are routinely vaccinated against rabies. Pets can also transmit ringworm and Giardia, which are endemic in both animal and human populations. Toxoplasmosis is a common infection of cats; in humans it is a mild disease although it can be dangerous to pregnant women.[52] Dirofilariasis is caused by Dirofilaria immitis through mosquitoes infected by mammals like dogs and cats. Cat-scratch disease is caused by Bartonella henselae and Bartonella quintana, which are transmitted by fleas that are endemic to cats. Toxocariasis is the infection of humans by any of species of roundworm, including species specific to dogs (Toxocara canis) or cats (Toxocara cati). Cryptosporidiosis can be spread to humans from pet lizards, such as the leopard gecko. Encephalitozoon cuniculi is a microsporidial parasite carried by many mammals, including rabbits, and is an important opportunistic pathogen in people immunocompromised by HIV/AIDS, organ transplantation, or CD4+ T-lymphocyte deficiency.[53]

Pets may also serve as a reservoir of viral disease and contribute to the chronic presence of certain viral diseases in the human population. For instance, approximately 20% of domestic dogs, cats, and horses carry anti-hepatitis E virus antibodies and thus these animals probably contribute to human hepatitis E burden as well.[54] For non-vulnerable populations (e.g., people who are not immunocompromised) the associated disease burden is, however, small.[55][56] Furthermore, the trade of non-domestic animals such as wild animals as pets can also increase the risk of zoonosis spread.[57][58]

Bats are frequently unjustly portrayed as the primary instigators of the ongoing COVID-19 epidemic; nevertheless, the true origins of this and other zoonotic spillover occurrences should be attributed to human environmental impacts, especially the proliferation of pets.[16] For example, bat predation by cats poses a significant danger to biodiversity conservation and carries zoonotic consequences that must be acknowledged.[16]

Exhibition

[edit]

Outbreaks of zoonoses have been traced to human interaction with, and exposure to, other animals at fairs, live animal markets,[59] petting zoos, and other settings. In 2005, the Centers for Disease Control and Prevention (CDC) issued an updated list of recommendations for preventing zoonosis transmission in public settings.[60] The recommendations, developed in conjunction with the National Association of State Public Health Veterinarians,[61] include educational responsibilities of venue operators, limiting public animal contact, and animal care and management.

Hunting and bushmeat

[edit]
Main articles: Hunting and Bushmeat

Hunting involves humans tracking, chasing, and capturing wild animals, primarily for food or materials like fur. However, other reasons like pest control or managing wildlife populations can also exist. Transmission of zoonotic diseases, those leaping from animals to humans, can occur through various routes: direct physical contact, airborne droplets or particles, bites or vector transport by insects, oral ingestion, or even contact with contaminated environments.[62] Wildlife activities like hunting and trade bring humans closer to dangerous zoonotic pathogens, threatening global health.[63]

According to the Center for Diseases Control and Prevention (CDC) hunting and consuming wild animal meat ("bushmeat") in regions like Africa can expose people to infectious diseases due to the types of animals involved, like bats and primates. Unfortunately, common preservation methods like smoking or drying aren't enough to eliminate these risks.[64] Although bushmeat provides protein and income for many, the practice is intricately linked to numerous emerging infectious diseases like Ebola, HIV, and SARS, raising critical public health concerns.[63]

A review published in 2022 found evidence that zoonotic spillover linked to wildmeat consumption has been reported across all continents.[65]

Deforestation, biodiversity loss and environmental degradation

[edit]
Main articles: Deforestation, Biodiversity loss, and Environmental degradation

Kate Jones, Chair of Ecology and Biodiversity at University College London, says zoonotic diseases are increasingly linked to environmental change and human behavior. The disruption of pristine forests driven by logging, mining, road building through remote places, rapid urbanization, and population growth is bringing people into closer contact with animal species they may never have been near before. The resulting transmission of disease from wildlife to humans, she says, is now "a hidden cost of human economic development".[66] In a guest article, published by IPBES, President of the EcoHealth Alliance and zoologist Peter Daszak, along with three co-chairs of the 2019 Global Assessment Report on Biodiversity and Ecosystem Services, Josef Settele, Sandra Díaz, and Eduardo Brondizio, wrote that "rampant deforestation, uncontrolled expansion of agriculture, intensive farming, mining and infrastructure development, as well as the exploitation of wild species have created a 'perfect storm' for the spillover of diseases from wildlife to people."[67]

Joshua Moon, Clare Wenham, and Sophie Harman said that there is evidence that decreased biodiversity has an effect on the diversity of hosts and frequency of human-animal interactions with potential for pathogenic spillover.[68]

An April 2020 study, published in the Proceedings of the Royal Society's Part B journal, found that increased virus spillover events from animals to humans can be linked to biodiversity loss and environmental degradation, as humans further encroach on wildlands to engage in agriculture, hunting, and resource extraction they become exposed to pathogens which normally would remain in these areas. Such spillover events have been tripling every decade since 1980.[69] An August 2020 study, published in Nature, concludes that the anthropogenic destruction of ecosystems for the purpose of expanding agriculture and human settlements reduces biodiversity and allows for smaller animals such as bats and rats, which are more adaptable to human pressures and also carry the most zoonotic diseases, to proliferate. This in turn can result in more pandemics.[70]

In October 2020, the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services published its report on the 'era of pandemics' by 22 experts in a variety of fields and concluded that anthropogenic destruction of biodiversity is paving the way to the pandemic era and could result in as many as 850,000 viruses being transmitted from animals – in particular birds and mammals – to humans. The increased pressure on ecosystems is being driven by the "exponential rise" in consumption and trade of commodities such as meat, palm oil, and metals, largely facilitated by developed nations, and by a growing human population. According to Peter Daszak, the chair of the group who produced the report, "there is no great mystery about the cause of the Covid-19 pandemic, or of any modern pandemic. The same human activities that drive climate change and biodiversity loss also drive pandemic risk through their impacts on our environment."[71][72][73]

Climate change

[edit]
Further information: Climate change and infectious diseases

According to a report from the United Nations Environment Programme and International Livestock Research Institute, entitled "Preventing the next pandemic – Zoonotic diseases and how to break the chain of transmission", climate change is one of the 7 human-related causes of the increase in the number of zoonotic diseases.[20][21] The University of Sydney issued a study, in March 2021, that examines factors increasing the likelihood of epidemics and pandemics like the COVID-19 pandemic. The researchers found that "pressure on ecosystems, climate change and economic development are key factors" in doing so. More zoonotic diseases were found in high-income countries.[74]

A 2022 study dedicated to the link between climate change and zoonosis found a strong link between climate change and the epidemic emergence in the last 15 years, as it caused a massive migration of species to new areas, and consequently contact between species which do not normally come in contact with one another. Even in a scenario with weak climatic changes, there will be 15,000 spillover of viruses to new hosts in the next decades. The areas with the most possibilities for spillover are the mountainous tropical regions of Africa and southeast Asia. Southeast Asia is especially vulnerable as it has a large number of bat species that generally do not mix, but could easily if climate change forced them to begin migrating.[75]

A 2021 study found possible links between climate change and transmission of COVID-19 through bats. The authors suggest that climate-driven changes in the distribution and robustness of bat species harboring coronaviruses may have occurred in eastern Asian hotspots (southern China, Myanmar, and Laos), constituting a driver behind the evolution and spread of the virus.[76][77]

Secondary transmission

[edit]

Zoonotic diseases contribute significantly to the burdened public health system as vulnerable groups such the elderly, children, childbearing women and immune-compromised individuals are at risk.[citation needed] According to the World Health Organization (WHO), any disease or infection that is primarily "naturally" transmissible from vertebrate animals to humans or from humans to animals is classified as a zoonosis.[78] Factors such as climate change, urbanization, animal migration and trade, travel and tourism, vector biology, anthropogenic factors, and natural factors have greatly influenced the emergence, re-emergence, distribution, and patterns of zoonoses.[78]

Zoonotic diseases generally refer to diseases of animal origin in which direct or vector mediated animal-to-human transmission is the usual source of human infection. Animal populations are the principal reservoir of the pathogen and horizontal infection in humans is rare. A few examples in this category include lyssavirus infections, Lyme borreliosis, plague, tularemia, leptospirosis, ehrlichiosis, Nipah virus, West Nile virus, and hantavirus infections.[79] Secondary transmission encompasses a category of diseases of animal origin in which the actual transmission to humans is a rare event but, once it has occurred, human-to-human transmission maintains the infection cycle for some period of time. Some examples include human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), certain influenza A strains, Ebola virus and severe acute respiratory syndrome (SARS).[79]

One example is Ebola, which is spread by direct transmission to humans from handling bushmeat (wild animals hunted for food) and contact with infected bats or close contact with infected animals, including chimpanzees, fruit bats, and forest antelope. Secondary transmission also occurs from human to human by direct contact with blood, bodily fluids, or skin of patients with or who died of Ebola virus disease.[80] Some examples of pathogens with this pattern of secondary transmission are human immunodeficiency virus/acquired immune deficiency syndrome, influenza A, Ebola virus, and SARS. Recent infections of these emerging and re-emerging zoonotic infections have occurred as a results of many ecological and sociological changes globally.[79]

History

[edit]

During most of human prehistory groups of hunter-gatherers were probably very small. Such groups probably made contact with other such bands only rarely. Such isolation would have caused epidemic diseases to be restricted to any given local population, because propagation and expansion of epidemics depend on frequent contact with other individuals who have not yet developed an adequate immune response.[81] To persist in such a population, a pathogen either had to be a chronic infection, staying present and potentially infectious in the infected host for long periods, or it had to have other additional species as reservoir where it can maintain itself until further susceptible hosts are contacted and infected.[82][83] In fact, for many "human" diseases, the human is actually better viewed as an accidental or incidental victim and a dead-end host. Examples include rabies, anthrax, tularemia, and West Nile fever. Thus, much of human exposure to infectious disease has been zoonotic.[84]

Possibilities for zoonotic disease transmissions

Many diseases, even epidemic ones, have zoonotic origin and measles, smallpox, influenza, HIV, and diphtheria are particular examples.[85][86] Various forms of the common cold and tuberculosis also are adaptations of strains originating in other species.[87][88] Some experts have suggested that all human viral infections were originally zoonotic.[89]

Zoonoses are of interest because they are often previously unrecognized diseases or have increased virulence in populations lacking immunity. The West Nile virus first appeared in the United States in 1999, in the New York City area. Bubonic plague is a zoonotic disease,[90] as are salmonellosis, Rocky Mountain spotted fever, and Lyme disease.

A major factor contributing to the appearance of new zoonotic pathogens in human populations is increased contact between humans and wildlife.[91] This can be caused either by encroachment of human activity into wilderness areas or by movement of wild animals into areas of human activity. An example of this is the outbreak of Nipah virus in peninsular Malaysia, in 1999, when intensive pig farming began within the habitat of infected fruit bats.[92] The unidentified infection of these pigs amplified the force of infection, transmitting the virus to farmers, and eventually causing 105 human deaths.[93]

Similarly, in recent times avian influenza and West Nile virus have spilled over into human populations probably due to interactions between the carrier host and domestic animals.[94] Highly mobile animals, such as bats and birds, may present a greater risk of zoonotic transmission than other animals due to the ease with which they can move into areas of human habitation.

Because they depend on the human host[95] for part of their life-cycle, diseases such as African schistosomiasis, river blindness, and elephantiasis are not defined as zoonotic, even though they may depend on transmission by insects or other vectors.[citation needed]

Use in vaccines

[edit]

The first vaccine against smallpox by Edward Jenner in 1800 was by infection of a zoonotic bovine virus which caused a disease called cowpox.[96] Jenner had noticed that milkmaids were resistant to smallpox. Milkmaids contracted a milder version of the disease from infected cows that conferred cross immunity to the human disease. Jenner abstracted an infectious preparation of 'cowpox' and subsequently used it to inoculate persons against smallpox. As a result of vaccination, smallpox has been eradicated globally, and mass inoculation against this disease ceased in 1981.[97] There are a variety of vaccine types, including traditional inactivated pathogen vaccines, subunit vaccines, live attenuated vaccines. There are also new vaccine technologies such as viral vector vaccines and DNA/RNA vaccines, which include many of the COVID-19 vaccines.[98]

Lists of diseases

[edit]
Main article: List of zoonotic diseases

See also

[edit]

References

[edit]

Bibliography

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Zoonosis

View on Grokipedia
from Grokipedia

Zoonosis is an infectious naturally transmitted between animals and humans, involving pathogens such as , viruses, parasites, or fungi that originate in animal reservoirs and spill over to human hosts.
These diseases constitute a major component of human infectious pathology, with over 60% of known infectious diseases in humans being zoonotic and approximately 75% of emerging infectious diseases arising from animal sources.
Transmission mechanisms include direct contact with infected animals or their tissues and fluids, indirect exposure through contaminated , , or environments, and vector-mediated spread via arthropods like ticks or mosquitoes.
Key examples encompass , which spreads through animal bites and remains nearly 100% fatal post-symptom onset without prompt intervention; , vectored by Ixodes ticks from rodent reservoirs; and bacterial infections like , often linked to or handling.
Zoonotic events are influenced by ecological disruptions such as habitat loss and intensified human-wildlife interfaces, underscoring the need for integrated surveillance across human, animal, and environmental sectors to mitigate spillover risks.

Fundamentals

Definition and Scope

Zoonosis refers to an infectious disease or infection that is naturally transmitted between animals and humans, with animals typically serving as the primary reservoir or source of the pathogen. These diseases arise when pathogens adapted to animal hosts spillover to humans, often requiring the pathogen to overcome species barriers for successful infection. Zoonotic agents include bacteria (such as species causing ), viruses (such as ), parasites (such as causing ), fungi, and prions, though the majority involve bacterial, viral, or parasitic etiologies. The scope of zoonoses encompasses over 200 recognized diseases worldwide, accounting for approximately 60% of all known pathogens and 75% of emerging or re-emerging infectious diseases reported since 1940. This prevalence underscores zoonoses as a leading cause of illness, responsible for an estimated 2.5 billion cases and 2.7 million deaths annually, with disproportionate impacts in regions of high human-animal interface such as rural or agricultural areas. While transmission is unidirectional from animals to humans in classical zoonoses, reverse zoonoses (anthroponoses) where humans infect animals can occur, complicating eradication efforts for shared pathogens like viruses; however, the core focus remains on animal-origin spillovers driven by ecological and behavioral factors. Zoonoses differ from purely human pathogens by their dependence on animal maintenance hosts, often wildlife or domestic species, which sustain the pathogen in nature without human intervention. This ecological dependency expands the scope beyond direct human-animal contact to include vector-borne (e.g., Lyme disease via ticks) and environmental pathways, emphasizing the need for interdisciplinary surveillance across veterinary, medical, and ecological domains to mitigate risks from habitat encroachment or intensified animal husbandry.

Classification of Zoonotic Agents

Zoonotic agents are classified primarily by their etiological type, encompassing , viruses, parasites (including and helminths), fungi, and unconventional agents such as prions. This categorization reflects the diverse biological mechanisms by which these pathogens infect animal reservoirs and transmit to humans. Bacterial agents constitute the most numerous category, surpassing viruses in the count of known zoonoses, followed by helminths, , and fungi. Bacterial Zoonotic Agents
Bacterial zoonoses include pathogens like species, which cause transmitted via contact with infected livestock or unpasteurized dairy products. species lead to , often through contaminated food from animal sources such as and reptiles. Other examples encompass (anthrax), (plague), (Lyme disease), and (bovine tuberculosis). , responsible for Q fever, spreads through inhalation of aerosols from infected animals. These typically require direct contact, , or vector mediation for transmission. Viral Zoonotic Agents
Viruses represent a significant category, with (Lyssavirus) transmitted via bites from infected mammals, causing nearly 59,000 human deaths annually, predominantly in Africa and Asia. viruses, including avian and swine strains, facilitate zoonotic spillover, as seen in the 2009 H1N1 pandemic originating from swine. Emerging threats include Ebola virus from bats and primates, via mosquitoes, and coronaviruses like , linked to bat reservoirs. Viral agents often exhibit high mutation rates, enabling adaptation across species barriers. Parasitic Zoonotic Agents
Parasites are subdivided into protozoan and helminth categories. Protozoa such as Toxoplasma gondii infect via oocysts from cat feces or undercooked meat, affecting over 40 million people in the U.S. alone. Cryptosporidium species cause waterborne cryptosporidiosis from contaminated animal-derived sources. Helminths include Toxocara species, roundworms from dogs and cats leading to visceral larva migrans, and cestodes like Echinococcus granulosus causing hydatid disease through contact with infected canids. These agents rely on complex life cycles involving intermediate and definitive hosts. Fungal Zoonotic Agents
Fungal zoonoses are less prevalent but include , acquired from or , causing primarily through inhalation. from avian excreta can lead to in immunocompromised individuals. These dimorphic fungi thrive in environmental niches associated with animal habitats, with transmission typically environmental rather than direct. Prion Zoonotic Agents
Prions, proteinaceous infectious particles lacking nucleic acids, represent unconventional agents, as in (BSE or "mad cow disease") from cattle, which crossed to humans as variant Creutzfeldt-Jakob disease via contaminated beef. in sheep and in deer pose potential risks, though human transmission remains unconfirmed beyond BSE. Prions propagate by inducing misfolding in host proteins, evading typical immune responses.

Transmission Mechanisms

Direct Animal-to-Human Contact

Direct animal-to-human transmission of zoonotic diseases occurs through physical interactions, including bites, scratches, abrasions, or handling of infected animal tissues, blood, placentas, fetuses, uterine secretions, or other body fluids, which introduce via breaks in the skin or mucous membranes. This mechanism bypasses intermediate vectors or environmental contamination, often posing risks to occupational groups like veterinarians, farmers, abattoir workers, and hunters who frequently manage live or slaughtered animals. Unlike vector-mediated or foodborne routes, contact emphasizes immediate proximity and unbarriered exposure, with transmission efficiency depending on pathogen viability in secretions and host susceptibility factors such as presence or immune status. Rabies exemplifies direct zoonotic transmission, primarily via the saliva of infected mammals entering through bites or scratches, though mucosal contact with saliva can also suffice. The , a , causes nearly 100% fatality once clinical symptoms appear, with global human deaths estimated at around 59,000 annually as of data up to 2015, predominantly from bites in endemic regions of and . In the United States, such as bats, raccoons, , and foxes account for over 90% of the approximately 4,000 reported animal cases yearly, with human exposures often linked to unprovoked bites or handling of infected carcasses. , including wound cleaning and vaccination, prevents progression in exposed individuals, underscoring the causal role of prompt intervention in breaking transmission. Brucellosis, caused by Brucella species , spreads directly through contact with infected or during handling, particularly reproductive tissues or aborted materials from , goats, sheep, or pigs. Humans ingest or inhale aerosols minimally in direct scenarios, but skin penetration from cuts during slaughter or birthing is a primary route, leading to chronic fever, joint pain, and organ involvement if untreated. Occupational incidence is elevated among herders and meat processors, with global underreporting masking the burden in endemic areas. Antibiotic regimens like combined with rifampin achieve cure rates over 90% in uncomplicated cases, highlighting the bacterium's intracellular persistence as a key pathogenic factor. Leptospirosis, induced by spirochetes, transmits via direct exposure to urine or blood from reservoir animals like , dogs, , or pigs, often penetrating mucous membranes or abraded skin during activities such as cleaning animal enclosures or wading in contaminated farm runoff. While indirect waterborne spread predominates, direct contact cases occur in veterinary settings or rural labor, manifesting as flu-like illness or severe Weil's disease with and renal failure in 5-10% of symptomatic infections. Annual global incidence exceeds 1 million cases, with higher rates in tropical regions tied to animal density and sanitation deficits. Preventive measures, including protective gloves and control, reduce risk by limiting serovar-specific exposure. Domestic dogs facilitate zoonotic transmission through direct contact with saliva via licks or bites, feces or urine, and infected skin or fur, with risks elevated under conditions of neglected vaccination, inadequate parasite treatment, and poor sanitation. These pathways complement examples like rabies from saliva and leptospirosis from urine, illustrating the role of companion animals in human exposures. Other pathogens like (anthrax) enter via cutaneous contact with spore-laden hides or carcasses, causing localized eschars in 95% of naturally occurring human cases, primarily among tanners and shepherds in endemic zones. These transmissions underscore the causal importance of barrier breaches and pathogen dose, with and antibiotics mitigating outbreaks in high-risk cohorts.

Vector-Mediated Transmission

Vector-mediated transmission occurs when a biological vector, typically an such as a , , , or , acquires a zoonotic from an infected animal during a , allows the pathogen to replicate or develop within its body, and subsequently transmits it to humans through another bite or contact. This process requires specific vector competence, including the pathogen's ability to survive the vector's immune responses, multiply in tissues like the salivary glands, and be expelled during feeding. Unlike mechanical transmission by contaminated body parts, vector-mediated spread involves an obligatory developmental phase in the vector, enabling efficient dissemination of , viruses, , or helminths. Arthropod vectors are the primary agents in zoonotic vector-borne diseases, which account for over 17% of all infectious diseases globally and cause more than 700,000 deaths annually, though many such as maintain primarily human cycles; true zoonoses often involve or reservoirs. es transmit flaviviruses like (WNV), where birds serve as amplifying hosts; in the United States, WNV caused 1,656 human disease cases in 2025, predominantly neuroinvasive, reflecting seasonal peaks from June to September. In , as of August 2025, eight countries reported 335 locally acquired WNV cases and 19 deaths, with leading due to vectors bridging avian and human populations. , another mosquito-vectored zoonosis from Phlebovirus, cycles in like sheep and cattle, with outbreaks triggered by flooding that boosts mosquito populations; human infections occur via bites or aerosols during epizootics. Ticks, particularly hard ticks like and species, mediate a diverse array of bacterial and viral zoonoses in the , transmitting the highest variety of arthropod-borne pathogens in the United States. , caused by spirochetes from rodent and deer reservoirs, exemplifies this; U.S. surveillance reported an average of 46,115 cases annually from 2019–2022, with Lyme comprising the majority and expanding via climate-driven tick range shifts. Other tick-borne zoonoses include ( from rodents), ( from ), and ( from dogs and small mammals), often co-circulating in endemic areas. Fleas and sandflies facilitate transmission of bacterial and protozoan zoonoses; Yersinia pestis, the plague agent, persists in rodent-flea cycles (e.g., Xenopsylla cheopis vectors from species), with sporadic bubonic cases reported globally, including 1–2 dozen annually in the U.S. from prairie dog reservoirs in the Southwest. , caused by protozoa, involves sandfly vectors (e.g., ) drawing from canine or rodent reservoirs, leading to visceral or cutaneous forms in endemic regions like the Mediterranean and .
DiseasePrimary VectorAnimal ReservoirKey Regions/Recent Data
Mosquitoes (Culex spp.)BirdsU.S.: 1,656 cases in 2025; Europe: 335 cases as of Aug 2025
Ticks ( spp.), deerU.S.: ~46,000 cases/year (2019–2022 avg.)
PlagueFleas (Xenopsylla cheopis)Global sporadic; U.S.: 1–24 cases/year
Mosquitoes ( spp.) (sheep, )/ outbreaks post-flooding
Transmission efficiency depends on vector density, biting rates, and environmental factors like , which accelerate pathogen extrinsic incubation periods; for instance, warmer conditions enhance questing and mosquito replication of arboviruses. Control relies on integrated vector management, including modification and application, though challenges arise from vector and reservoir persistence in sylvatic cycles.

Foodborne and Waterborne Pathways

Foodborne transmission of zoonotic pathogens typically involves the consumption of animal-derived products contaminated during slaughter, processing, or handling, such as undercooked , unpasteurized , or eggs harboring from infected . Common agents include Salmonella enterica, which colonizes the intestines of , , and pigs, leading to approximately 1.35 million cases annually , with as a primary reservoir. , prevalent in intestines, causes over 800,000 U.S. illnesses yearly, often from raw or undercooked . , transmissible via contaminated dairy or processed meats from carrier animals, results in about 1,600 U.S. cases annually, disproportionately affecting vulnerable populations with a 20% fatality rate. Parasites like , shed in cat feces but acquired via undercooked or lamb, infect an estimated 11% of , with oocysts persisting in contaminated soil or water used in food production. Waterborne zoonoses arise from ingestion or dermal contact with water sources polluted by urine or feces from infected mammals, reptiles, or birds, facilitating pathogen survival in aquatic environments. spp., excreted in or urine, cause , with global incidence exceeding 1 million cases yearly, often linked to flooding or recreational water exposure in endemic areas. Protozoans such as Cryptosporidium parvum, originating from feces, resist chlorination and trigger outbreaks via contaminated , as seen in the 1993 Milwaukee incident affecting over 400,000 people. from or runoff similarly persists in surface waters, contributing to traveler's and contaminations worldwide.
PathogenReservoir AnimalsTransmission VehicleAnnual Global Burden Estimate
Salmonella spp., , pigsUndercooked meat, eggs93 million cases
Campylobacter spp., Raw poultry, milk96 million cases
Leptospira spp., dogs, Contaminated floodwater, recreational water>1 million cases
Cryptosporidium parvum, Untreated Millions in outbreaks
These pathways underscore the role of agricultural runoff and inadequate in amplifying risks, with foodborne zoonoses accounting for roughly 420,000 deaths globally from diarrheal diseases tied to contaminated animal sources. relies on cooking meats to safe internal temperatures (e.g., 74°C for ), pasteurization, and like and UV disinfection, reducing incidence by over 90% in controlled settings.

Aerosol and Environmental Exposure

Aerosol transmission in zoonoses involves the of pathogen-laden airborne particles generated from infected animals, their bodily fluids, or contaminated materials, often without direct contact. This mechanism is facilitated by activities such as cleaning enclosures, handling birth products, or processing , which aerosolize droplets or dust containing viable microbes. Pathogens like , the agent of , exemplify this route due to their low infectious dose—reportedly as few as one via —and resilience in , enabling dispersal over distances up to several kilometers, as observed in outbreaks linked to wind-blown particles from infected farms. Q fever transmission peaks during lambing seasons, with documented cases tied to from contaminated dust in environments, affecting abattoir workers and nearby residents. Hantaviruses, responsible for hantavirus pulmonary syndrome (HPS), are transmitted primarily through aerosols created by disturbing dried excreta, urine, or nesting materials in enclosed spaces like cabins or barns. In the Americas, Sin Nombre virus carried by deer mice (Peromyscus maniculatus) has caused HPS cases with case-fatality rates of 30–40%, where exposure occurs during activities such as sweeping infested areas, generating respirable virus particles that remain viable in air for hours. Environmental factors, including population surges in disturbed habitats, amplify risk by increasing the volume of contaminated aerosols. Avian influenza viruses, particularly highly pathogenic strains like H5N1, can spread via aerosols during poultry slaughter or feather plucking, where infectious droplets exceed viable thresholds for human inhalation, as demonstrated in experimental processing of infected birds yielding higher aerosol loads than from ducks. Psittacosis, caused by Chlamydia psittaci, similarly arises from inhaling feather dust or dried droppings from infected birds, with occupational clusters among bird handlers. These pathogens' environmental persistence—C. burnetii surviving months in soil or dust—extends exposure risks beyond immediate animal proximity, through indirect contact with contaminated fomites or wind-dispersed particles in rural or semi-enclosed settings.

Risk Factors

Human Behavioral and Economic Drivers

Human behaviors that increase contact with potential zoonotic reservoirs include wild animals for , which has been associated with virus spillovers through handling infected carcasses, as observed in multiple outbreaks in since the 1970s. Consumption of undercooked wildmeat, particularly from and bats, facilitates via oral-fecal routes or direct contact with contaminated tissues, contributing to the origins of from simian viruses in trade chains in early 20th-century . Occupational exposure among hunters, farmers, and market vendors heightens risks, as evidenced by transmissions from date palm sap contaminated by bat saliva in , where harvesters' practices enable spillover. Live animal markets, or wet markets, promote cross-species mixing that amplifies spillover potential; for instance, the sale of wildlife alongside domestic animals in Asian markets has been linked to severe acute respiratory syndrome coronavirus (SARS-CoV) emergence in 2002–2003 and suspected for SARS-CoV-2 in 2019, involving high-density confinement of susceptible hosts like civets and raccoon dogs. Cultural practices, such as using animal parts in traditional medicines, further drive handling of exotic species, increasing exposure to pathogens like those causing monkeypox through rodent trade in West Africa. Ecotourism and informal pet trade, including keeping wild animals as exotic pets, introduce additional interfaces, as seen in outbreaks of avian influenza among bird handlers and tourists interacting with poultry in Southeast Asia. Economic pressures exacerbate these behaviors by incentivizing reliance on high-risk activities; poverty in rural compels communities to hunt and forage in habitats due to limited access to domestic protein sources, as documented in where displaced populations in tsetse-infested areas face elevated risks from such livelihoods. In urban slums of developing regions, economic marginalization correlates with poor and proximity to reservoirs, elevating incidence through behaviors like informal waste handling, with cases surging in Brazilian cities post-floods due to density-dependent exposures. Wildlife trade networks, driven by demand for , pets, and traditional remedies, generate economic incentives for capture and transport, involving millions of animals annually across and and facilitating pathogen dispersal, as in the global spread of via migratory birds and human-mediated shipments. Informal economies in pastoral regions, such as Kenya's arid zones where 70% rates limit veterinary services, force livestock-wildlife commingling during droughts, amplifying transmission through economic necessities like shared . Large-scale investments in and agriculture displace smallholders into disease-prone fringes, undermining sustainable livelihoods and intensifying zoonotic vulnerabilities, as observed in Sierra Leone's rural economies prior to the 2014 outbreak. These drivers interact with global travel, where economic migration and tourism networks accelerate secondary spread post-spillover, underscoring poverty's role in perpetuating cycles of exposure and limited mitigation capacity.

Animal Husbandry and Trade Practices

Intensive practices, particularly in large-scale commercial operations, create conditions conducive to zoonotic amplification through high stocking densities, limited , and chronic stress on , which can suppress immune responses and promote viral mutations. For instance, highly pathogenic (HPAI) H5N1 outbreaks in farms have demonstrated how confined environments enable rapid intra-species spread, with the first commercial flock confirmation occurring on February 8, 2022, followed by widespread detections across operations housing millions of birds. Similarly, swine production systems have been linked to influenza A reassortment events, as seen in the 2009 H1N1 pandemic origins tracing to in regions with mixed practices. Global trade in live animals exacerbates these risks by facilitating the movement of infected individuals across borders, often without adequate , allowing pathogens to bypass geographic barriers. The , as the world's largest importer of , has imported harboring potential zoonoses, with studies identifying pathogens in traded animals that could spill over to humans or domestic . Live animal markets, where diverse are co-mingled under unsanitary conditions, heighten spillover probabilities; emergence in 2002 was associated with such markets in southern , where civets and other were sold alongside humans. Wildlife trade chains, including harvesting and markets, introduce additional vulnerabilities by stressing wild-caught animals and enabling prior to human contact. Pathogens like and monkeypox have been documented in traded , with illegal networks mixing non-native and amplifying emergence risks through poor enforcement. While some analyses suggest intensive farming may limit wildlife-livestock interfaces compared to extensive systems, empirical outbreak data indicate that industrial-scale operations still serve as amplifiers once pathogens enter, underscoring the need for enhanced in both husbandry and pathways.

Environmental and Habitat Alterations

through has been associated with heightened zoonotic spillover risks by forcing wildlife into closer proximity with human settlements, thereby increasing opportunities for . For instance, in tropical regions, rapid forest clearance for and disrupts animal reservoirs, elevating human exposure to viruses like , where outbreaks have correlated with bushmeat hunting in deforested areas of . Similarly, studies in link to increased spillover of arboviruses such as and Zika, as fragmented habitats concentrate competent hosts like mosquitoes and primates near human populations. Biodiversity loss exacerbates these risks by altering host-pathogen dynamics; reduced can amplify the prevalence of zoonotic pathogens in remaining populations, as dominant species become superspreaders. Empirical analyses indicate that correlates with higher incidence of diseases like hantavirus and , where loss of natural buffers diminishes dilution effects from diverse ecosystems. Agricultural intensification, often involving land conversion, further compounds this by creating interfaces where and intermingle, facilitating jumps such as from bats to pigs and humans in in 1998–1999. Climate-driven habitat shifts, including range expansions of vectors and reservoirs due to warming temperatures, have enabled northward spread of zoonoses like in and in . For example, altered precipitation and temperature patterns have expanded mosquito habitats, correlating with dengue emergence in previously temperate zones. Urban expansion into peri-wildland areas similarly heightens exposure; construction and water body alterations in have been tied to increased human-bat contacts, precursors to coronaviral spillovers. These changes underscore causal pathways where reduces ecological barriers, though direct attribution requires site-specific to distinguish from other factors like .

Epidemiology

Global Disease Burden

Zoonotic diseases impose a substantial burden on global , accounting for an estimated 2.5 billion cases of human illness and 2.7 million deaths annually. More than 60% of known infectious diseases in humans are zoonotic in origin, with approximately 75% of emerging infectious diseases arising from animal reservoirs. This burden is disproportionately borne by low- and middle-income countries, where limited surveillance and control measures exacerbate morbidity and mortality from pathogens such as , which causes around 59,000 deaths per year, primarily in and . Neglected zoonotic diseases (NZDs), including , , and , contribute significantly to disability-adjusted life years (DALYs) lost, with global estimates indicating at least 21 million DALYs annually from selected NZDs alone. These figures underscore the underreported nature of many zoonoses, particularly in resource-poor settings where human-animal interfaces are intensive. Foodborne zoonoses, such as those from and , add to the tally, with unsafe food causing 600 million illnesses and 420,000 deaths yearly, a portion attributable to animal sources. Economically, zoonoses generate direct costs exceeding $20 billion over the past decade from treatment and control, alongside indirect losses over $200 billion from depopulation, trade restrictions, and reduced productivity. Recent analyses suggest broader annual global costs ranging from $1 trillion to $6.7 trillion when factoring in potentials and systemic disruptions, highlighting the need for integrated approaches to mitigate spillover risks. Despite these estimates, data gaps persist due to inconsistent reporting and varying methodologies, potentially understating the true burden in wildlife-dominated ecosystems.

Surveillance Methods and Challenges

Surveillance of zoonotic diseases integrates human, animal, and monitoring under the framework, coordinated by organizations such as the (WHO), (FAO), and (WOAH). This approach employs passive surveillance, where cases are reported through existing health systems, and active surveillance, involving targeted sampling of reservoirs like , , and vectors such as mosquitoes. For instance, the U.S. Centers for Disease Control and Prevention (CDC) conducts active bacterial core surveillance for invasive zoonotic s and pools vector samples for pathogen detection. Advanced methods include syndromic surveillance to detect unusual patterns in symptoms or animal behaviors before laboratory confirmation, and genomic sequencing to trace pathogen origins and . The Tripartite's Surveillance and Information Sharing Operational Tool facilitates data exchange across sectors, while global systems like the WHO-FAO-WOAH Global Early Warning System integrate alerts for emerging threats. In wildlife, trap-and-test protocols enumerate species and screen for pathogens, though coverage remains uneven. Challenges persist in achieving comprehensive coverage, particularly in detecting silent spillovers in remote or under-monitored populations, where early signals may go unnoticed until human cases emerge. Weak diagnostic capacity and reporting in low-resource regions contribute to underreporting; for example, many endemic zoonoses evade detection due to limited serological or molecular testing infrastructure. Intersectoral coordination remains fragmented, with governance issues hindering across human , veterinary, and environmental agencies, both nationally and internationally. Emerging pathogens often lack predefined surveillance protocols, complicating rapid response, while resistance to integrated systems stems from jurisdictional silos and resource constraints. In the U.S., federal agencies like the USDA's Animal and Plant Health Inspection Service (APHIS) and U.S. Geological Survey (USGS) face gaps in monitoring , as noted in a 2023 Government Accountability Office report. Global efforts, such as CDC's work in over 90 countries, underscore the need for enhanced capacity-building to address these barriers.

Recent Outbreaks (2020–2025)

The virus, responsible for the , is widely regarded as having zoonotic origins through spillover from bats, potentially via an intermediate host such as raccoon dogs or sold at the in , , where early cases clustered in December 2019 and January 2020. Genetic analyses indicate the virus's closest relatives in bats and the market's role in initial amplification, with environmental samples from stalls testing positive for alongside susceptible animal DNA. By March 2020, the declared a , leading to over 700 million confirmed cases and 7 million deaths globally by 2023, though underreporting likely inflated these figures; the zoonotic remains supported by phylogenetic but contested by lab-leak theories lacking direct empirical validation. In May 2022, a global outbreak of mpox (formerly monkeypox) emerged, with initial cases detected outside endemic African regions, totaling over 97,000 confirmed infections across 118 countries by mid-2024. Primarily transmitted human-to-human via close contact, the outbreak traced to zoonotic reservoirs in African , with genetic evidence showing sustained circulation in human networks following spillover events; campaigns with smallpox-derived vaccines curbed spread in non-endemic areas, though cases persisted in , exceeding 100,000 globally by late 2025. Highly pathogenic A(H5N1) saw expanded circulation starting in 2020, affecting wild birds, , and mammals across all continents except , with spillover to s via direct contact with infected animals. cases remained sporadic, totaling around 990 laboratory-confirmed globally from 2003 to August 2025, including 70 in the United States since March 2024—mostly among and workers—with one fatality and mild symptoms predominating due to limited human adaptation. Marburg virus disease outbreaks occurred in 2023, including 16 confirmed cases (12 deaths) in from February to June and additional clusters in , linked to fruit reservoirs and human exposure through or practices in endemic areas. These events underscored ongoing risks in , with case-fatality rates exceeding 80% absent supportive care, prompting enhanced but no sustained international spread.

History

Early Observations and Discoveries

Ancient DNA analyses of over 1,300 prehistoric remains spanning 37,000 years reveal that zoonotic pathogens first appeared in populations around 6,500 years ago, coinciding with the onset of animal domestication and husbandry practices in and . These early zoonoses, including bacterial strains like Yersinia pestis precursors, peaked in prevalence approximately 5,000 years ago, suggesting increased spillover risks from livestock proximity. Prior to this period, no genetic evidence of such cross-species transmissions exists in sampled populations, indicating zoonoses emerged as a consequence of sedentary farming and herding rather than lifestyles. The earliest documented historical account of a zoonotic disease appears in the Code of circa 2300 BCE, which records fatalities in dogs and humans, imposing fines for owners of rabid animals that transmitted the condition via bites. By 556 BCE, Chinese records describe outbreaks, attributing symptoms like hydrophobia and aggression to infected canines. Greek philosopher provided one of the first detailed descriptions around 500 BCE, noting the transmission of "madness" from rabid dogs to humans through saliva, emphasizing the fatal progression if untreated. These observations highlight as a prototypical zoonosis, with animal reservoirs—primarily dogs—recognized as the source long before microbial causation was understood. Plague (Yersinia pestis) outbreaks were observed as early as 224 BCE in , marking the first major recorded , though links to vectors were not established until centuries later. Biblical texts around 1320 BCE describe a Philistine plague involving swollen lymph nodes and mouse overpopulation, retrospectively interpreted as spillover from rodents. The Justinian Plague (541–546 CE), originating in and spreading across the , killed an estimated 100 million, with contemporary accounts noting sudden die-offs in rats preceding human cases. Similarly, was referenced in ancient Greek texts, including Homer's (circa 8th century BCE), as a murrain afflicting and spilling over to handlers via contaminated hides or , though explicit transmission mechanisms remained anecdotal until the . In the , experimental confirmation advanced recognition: Heinrich Zinke demonstrated transmission via saliva in 1804 by inoculating rabbits with dog saliva. German pathologist coined the term "zoonosis" in 1855 to denote diseases communicable between animals and humans, based on studies of Trichinella spiralis in swine affecting consumers, underscoring the need for integrated human-animal health oversight. These pre-20th-century insights, drawn from epidemic patterns and rudimentary experiments, laid groundwork for understanding zoonotic dynamics without modern , revealing patterns tied to animal contact in agrarian societies.

20th-Century Recognitions and Eradications

The 20th century marked significant advancements in identifying zoonotic pathogens, driven by improved microbiological techniques and epidemiological investigations. , caused by the bacterium and primarily transmitted from livestock such as , sheep, and goats, was first documented in 1935 during an outbreak among Australian abattoir workers, with the pathogen isolated two years later, confirming its rickettsial nature and airborne transmission via contaminated dust or aerosols. Similarly, (now ornithosis), caused by and spread from infected birds like parrots, gained recognition as a distinct zoonosis following epidemics in the and , particularly after a 1929–1930 outbreak in the United States linked to imported pet birds. Viral zoonoses also saw key recognitions, particularly hemorrhagic fevers. Marburg virus, the first identified filovirus, emerged in 1967 among laboratory workers in Germany handling African green monkeys imported from Uganda, establishing its zoonotic spillover from fruit bats or non-human primates. Lassa fever, caused by Lassa mammarenavirus and transmitted via multimammate rats, was isolated in 1969 from a nurse in Nigeria, revealing its rodent reservoir and high case-fatality rate in West Africa. Ebola virus disease was recognized in 1976 during simultaneous outbreaks in Sudan and the Democratic Republic of Congo, with genetic analysis later confirming bat reservoirs and primate intermediates in transmission to humans. Lyme disease, caused by Borrelia burgdorferi and vectored by Ixodes ticks from rodents and deer, was identified in 1975 amid a cluster of arthritis cases in Lyme, Connecticut, highlighting ecological changes in tick habitats. The zoonotic origins of were retrospectively traced to early 20th-century hunting in , where simian immunodeficiency viruses (SIVs) from chimpanzees crossed into humans around the , evolving into HIV-1 and sparking a global epidemic by the 1980s; phylogenetic evidence supports multiple independent spillovers, with urban migration and medical practices amplifying spread. Eradication of zoonoses proved elusive due to persistent animal reservoirs, but control measures yielded substantial reductions. Bovine , caused by and transmissible via unpasteurized milk or aerosols from infected , saw near-elimination in U.S. herds through mandatory testing, slaughter of reactors, and starting in the early 1900s; by 1978, the national herd was declared free of the disease, dropping human cases from thousands annually pre-1950 to under 200 by century's end. , caused by species from , was similarly curtailed in the United States via the Brucellosis Eradication Program initiated in 1947, combining , , and depopulation, reducing human incidences from over 6,000 cases yearly in the 1940s to fewer than 100 by the 1990s. control advanced through dog campaigns, as domestic dogs accounted for most human cases; global efforts reduced annual deaths from tens of thousands, though reservoirs like foxes and bats persisted, necessitating ongoing surveillance established via the CDC's 1947 Veterinary Public Health Division targeting alongside and . Yellow fever's urban transmission was effectively curbed in many regions after the 1937 development of the 17D by , which interrupted aegypti-mosquito cycles in human-animal interfaces, though sylvatic cycles in monkeys endured. These efforts underscored the causal role of veterinary interventions in mitigating zoonotic risks, though full eradications remained unattainable without eliminating wildlife reservoirs.

Post-2000 Pandemics and Spillovers

The severe acute respiratory syndrome () epidemic, caused by , emerged in November 2002 in , Province, , through zoonotic spillover from horseshoe bats via intermediate hosts like masked palm civets traded in wildlife markets. The virus spread globally to 29 countries via human-to-human transmission, infecting 8,096 people and causing 774 deaths by July 2003, with a of approximately 10%. Retrospective genetic analyses confirmed the bat origin, with market-linked cases showing direct links to animal reservoirs. The 2009 influenza A(H1N1) , known as flu, originated from a triple reassortant circulating in North American swine herds, combining genes from , avian, and strains, with initial spillover to humans likely in in early 2009. First laboratory-confirmed cases appeared in and in late March 2009, prompting WHO to declare a on June 11, 2009; global estimates indicate 11-21 billion infections and 151,700-575,400 excess deaths, predominantly among younger populations. Genomic sequencing traced the virus's swine ancestry, highlighting industrial pig farming as a key amplification site for reassortment. Middle East respiratory syndrome (MERS), caused by MERS-CoV, was first detected in June 2012 in and , with dromedary camels serving as the primary zoonotic reservoir through repeated spillovers facilitated by close human-camel contact in the . By 2023, over 2,600 laboratory-confirmed human cases and 935 deaths were reported, yielding a of about 35%, mostly from nosocomial clusters rather than sustained community transmission. Serological evidence in camels dates infections back to at least 1983, with juvenile camels showing higher viral shedding and seasonal peaks aligning with human cases. Multiple virus disease (EVD) outbreaks post-2000 underscored recurrent zoonotic spillovers from fruit bats and non-human primates in Central and . The 2014-2016 epidemic, initiated by a spillover in in December 2013, expanded to and , recording 28,616 cases and 11,310 deaths across three countries, with a 40% . Genetic analyses linked it to prior Central African strains, with handling as a probable exposure route. Subsequent outbreaks, such as the 2018-2020 of Congo event with 3,481 cases and 2,299 deaths, involved independent spillovers, often in forested regions with high wildlife-human interface. The , driven by , began with cases in , Province, , in December 2019, with metagenomic and epidemiological evidence pointing to zoonotic spillover from bats via susceptible wildlife species at the , where animal genetic material co-localized with early human infections.00901-2) By October 2023, it had caused over 770 million confirmed cases and 7 million deaths globally, with sustained human-to-human spread amplifying the initial spillover. Phylogenetic studies trace the virus to sarbecoviruses in Rhinolophus bats in , with receptor-binding adaptations suggesting intermediate host adaptation prior to human emergence. Highly pathogenic A(H5N1) has caused sporadic zoonotic spillovers since 2003, primarily from to humans in and beyond, with over 900 human cases and a 52% fatality rate reported by 2023, though no sustained human transmission. 2.3.4.4b variants have spilled over to wild birds, mammals, and U.S. by 2024, raising risk through expanded host range. These events highlight evolving viral ecology amid trade and habitat changes.

Notable Zoonotic Diseases

Viral Pathogens

Viral zoonoses arise when viruses adapted to animal hosts spill over to humans, often facilitated by close contact with , , or their products, leading to outbreaks ranging from localized infections to pandemics. Reservoirs for many such viruses include bats, birds, , and , with transmission typically occurring through bites, scratches, aerosols, or consumption of infected tissues. These pathogens exploit similarities in host receptors, enabling adaptation via mutations or recombination, though human-to-human spread can amplify impact post-spillover. Empirical evidence from genomic sequencing and serological surveys supports wildlife origins for most notable cases, with emphasizing early detection in animal populations to mitigate risks. Rabies exemplifies a classic zoonotic rhabdovirus, belonging to the genus, with global reservoirs in mammals including dogs, foxes, raccoons, and bats. In regions where canine persists, unvaccinated dogs account for over 99% of the approximately 59,000 annual human deaths, predominantly via bites transmitting saliva-borne virus. Bat-associated variants dominate in the , causing sporadic human cases through undetected exposures. The virus targets the , yielding near-100% fatality post-symptom onset without prompt , underscoring vaccination's role in reservoir control. Influenza A viruses demonstrate recurrent zoonotic potential from avian and hosts, with subtypes like H5N1 and H7N9 spilling over via poultry markets or direct bird contact, infecting over 900 humans since 1997 with case fatality rates exceeding 50% for H5N1. Swine serve as "mixing vessels" for reassortment between human, avian, and porcine strains, as seen in the 2009 H1N1 originating from triple-reassortant in , which spread globally after initial pig-to-human jumps. Wild birds maintain diverse subtypes in sylvatic cycles, with domestic amplification heightening spillover risks during intensified farming. Filoviruses such as originate in fruit bats of the Pteropodidae family, suspected natural based on serological and virological detection in species like Eidolon helvum, with non-human acting as amplifying hosts via hunting. Outbreaks, first recognized in 1976 near the , involve human infection through contact with infected primate carcasses or bat secretions, yielding case fatality rates of 25-90% across 30+ epidemics. Genomic analyses trace strains to bat ancestors, with no sustained human , emphasizing and mining activities in as drivers. Coronaviruses highlight reservoirs for sarbecoviruses, with SARS-CoV-2's closest relatives in Rhinolophus showing 96% genomic similarity, suggesting spillover likely via an unidentified intermediate host like pangolins, detected with related spike proteins at wildlife markets in in late 2019. Prior spillovers include from horseshoe via in 2002-2003, causing 774 deaths, and MERS-CoV from camels (with origins) in , with over 2,500 cases. Human adaptation occurs through receptor-binding domain mutations enhancing ACE2 affinity, but direct bat-to-human jumps remain rare without amplification. Lentiviruses like HIV-1 trace to of (SIVcpz) from central African chimpanzees (Pan troglodytes troglodytes) to s around the early , likely via butchering exposing blood or tissues. Phylogenetic evidence links HIV-1 group M, responsible for the global pandemic with over 40 million deaths, to SIVcpz strains enzootic in chimp communities, with adaptations in viral accessory proteins enabling efficient replication. Chimpanzees acquired SIV via predation on infected monkeys, illustrating serial zoonoses preceding emergence.

Bacterial Pathogens

Bacterial zoonoses encompass a diverse group of infections primarily transmitted from animal reservoirs to humans through direct contact with infected tissues or fluids, of contaminated or , of aerosols, or arthropod vectors such as ticks and fleas. These pathogens often persist in , , or , with occupational exposure in , veterinary work, and posing elevated risks. Unlike viral zoonoses, many bacterial agents respond to antibiotics, yet underreporting and diagnostic challenges contribute to significant global morbidity, particularly in resource-limited settings.
PathogenPrimary ReservoirsMain Transmission ModesEstimated Global Human Burden
spp. (brucellosis), sheep, , Unpasteurized , contact with aborted fetuses or tissues~2.1 million cases annually
spp. (), , ; urine-contaminated Contact with urine or water, occupational (e.g., farming, flooding)~1 million cases, ~59,000 deaths annually
() (, sheep, ), ticksInhalation of birth products aerosols, contaminated or Sporadic; outbreaks up to 4,000 cases (e.g., 2007–2010); underreported globally
(plague), fleasFlea bites, (pneumonic form), handling infected animalsHundreds of cases annually, mostly ; case-fatality ~7–10% with treatment
()Rabbits, hares, , ticksTick/mosquito bites, contact with infected animals, , contaminated Endemic in ; low hundreds of cases yearly in affected regions
()Herbivores (, sheep, ), soil sporesCutaneous via hides/meat handling (>95% of cases), , ingestionSporadic outbreaks; thousands in endemic areas like / during livestock die-offs
spp. (non-typhoidal ), reptiles, Contaminated food (eggs, meat), feces~93 million cases, ~155,000 deaths annually (foodborne share)
spp. (iosis), , pets, Undercooked poultry, unpasteurized , contaminated ~1.5 million cases annually in high-income countries alone; leading bacterial globally
Brucellosis manifests as undulant fever, joint pain, and , with chronic complications if untreated; it thrives in endemic areas due to unpasteurized consumption and poor . often presents with fever, , and renal failure, exacerbated by floods exposing humans to urine; tropical regions bear the heaviest burden. typically causes self-limiting flu-like illness but can lead to in vulnerable individuals, with from parturient amplifying risks during birthing seasons. Plague remains a threat in sylvatic cycles among rodents, with bubonic form via flea vectors and pneumonic via respiratory droplets; modern antibiotics reduce fatality, but delays in endemic foci like Madagascar sustain outbreaks. Tularemia, highly infectious at low doses, causes ulceroglandular syndrome or pneumonic disease; tick season and hunting activities drive seasonal spikes in the U.S. and Eurasia. Anthrax's spore-forming nature enables environmental persistence, with cutaneous lesions from handling contaminated animal products predominant; gastrointestinal and inhalational forms are rarer but more lethal. Foodborne bacterial zoonoses like and campylobacteriosis account for substantial acute diarrhea burdens, often linked to processing; Salmonella invades via contaminated eggs or meat, while dominates raw chicken exposures, with Guillain-Barré syndrome as a rare . Control hinges on , cooking, hygiene, and , yet antimicrobial resistance in reservoirs complicates management. Emerging patterns, including interfaces, underscore ongoing spillover risks.

Parasitic and Other Agents

Parasitic zoonoses encompass protozoan and helminth infections transmitted from animal reservoirs to humans, often via contaminated food, water, or direct contact. , a protozoan parasite, causes , primarily through ingestion of oocysts in cat feces or tissue cysts in undercooked meat from intermediate hosts like pigs or sheep; it infects an estimated one-third of the global human population, with congenital transmission leading to severe outcomes such as or in newborns. In immunocompromised individuals, acute infection can disseminate to the brain or lungs, causing . Helminthic zoonoses include echinococcosis, caused by Echinococcus granulosus or E. multilocularis, where dogs and foxes serve as definitive hosts shedding eggs in feces; humans acquire cystic or alveolar forms via ingestion, leading to hydatid cysts primarily in the liver or lungs, with an estimated 1 million cases worldwide and annual deaths exceeding 19,000, predominantly in pastoral regions of the Mediterranean, South America, and Asia. Cysticercosis, from the larval stage of Taenia solium (pork tapeworm), transmits zoonotically when humans ingest eggs from human feces contaminated by carriers, resulting in neurocysticercosis—the leading cause of adult-onset epilepsy in endemic areas like Latin America, sub-Saharan Africa, and Asia, with over 2.5 million cases globally. Trichinellosis, induced by nematodes of the genus Trichinella (e.g., T. spiralis), occurs via consumption of undercooked meat from carnivorous or scavenging mammals like wild boar or bears; U.S. cases, though rare (averaging 10-20 annually), often link to non-commercial game, with symptoms including myalgia, fever, and periorbital edema, potentially fatal in severe infections due to cardiac or neurological involvement. Other agents include prions, misfolded proteins causing transmissible spongiform encephalopathies. Variant Creutzfeldt-Jakob disease (vCJD), the only confirmed zoonotic prion illness, arose from consumption of bovine spongiform encephalopathy (BSE)-infected beef during the 1980s-1990s UK outbreak, with 232 cases reported globally by 2024, all fatal and characterized by progressive dementia, ataxia, and psychiatric symptoms typically in younger adults. Zoonotic fungal agents, such as Sporothrix schenckii in sporotrichosis, transmit via scratches from infected cats, causing cutaneous ulcers that can disseminate in immunocompromised hosts; outbreaks, notably in Brazil since 1998, highlight emerging risks in veterinary settings.

Prevention and Control

Veterinary and Agricultural Interventions

Veterinary interventions for zoonotic disease prevention primarily involve of reservoir animal populations to interrupt transmission chains. For instance, mass vaccination campaigns targeting domestic s have proven effective against , a fatal zoonosis responsible for approximately 59,000 human deaths annually, predominantly in and ; achieving 70% coverage in dog populations can eliminate canine rabies and thereby prevent human cases. Similarly, livestock vaccination programs against , , and reduce bacterial shedding from infected animals, minimizing spillover risks to humans through , , or direct contact. These efforts are supported by organizations like the , which emphasize vaccinating domestic species to curb neglected zoonoses, though challenges include accessibility in low-resource settings and the need for cold-chain infrastructure. Agricultural measures form a foundational barrier against zoonotic pathogens entering chains or communities. These include strict protocols, such as disinfection of facilities, segregation of species to prevent cross-infection, and barriers to exclude wildlife vectors like or birds that can introduce pathogens such as or . The recommends integrated farm-level practices, including controlled access to premises and , which have reduced outbreak incidences in and swine operations; for example, implementing minimum standards in Vietnamese hatcheries lowered risks. of newly introduced animals for 21–30 days, depending on the species and disease, allows for health screening and prevents introduction of subclinical carriers. Active surveillance and diagnostic testing in herds and flocks enable early detection and targeted interventions. Routine serological testing for pathogens like or Toxoplasma in identifies infected animals for isolation or removal, preventing amplification within agricultural settings. Treatment of clinical cases with antimicrobials, where applicable, curbs bacterial zoonoses such as campylobacteriosis, though judicious use is critical to avoid fostering resistance that could exacerbate threats. In outbreak scenarios, of infected or exposed animal populations remains a rapid containment strategy for high-risk zoonoses. During highly pathogenic (HPAI) H5N1 epizootics, depopulation of affected flocks—often combined with movement restrictions—has limited viral spread to humans, as seen in multiple global incidents since 2003 where prevented widespread to mammalian hosts. Similarly, ring around infected premises for diseases like African swine fever reduces secondary transmissions, though efficacy depends on timely and compensation for farmers to ensure compliance. These measures, while effective in breaking transmission cycles, must balance with ecological impacts, as indiscriminate wildlife has shown limited long-term benefits for control.

Human Public Health Strategies

Public health strategies for zoonotic diseases emphasize early detection, rapid response, and behavioral interventions to interrupt transmission from animal reservoirs to humans. These approaches integrate surveillance systems that monitor human cases alongside animal and environmental indicators, as outlined in the framework, which recognizes interconnections between human, animal, and to optimize prevention efforts. Coordinated actions, including multisectoral collaboration, form the basis for frameworks that address emerging threats through shared data and joint protocols. Surveillance and monitoring constitute the cornerstone of human-focused zoonosis control, enabling timely identification of spillovers. Integrated systems track human infections via syndromic reporting, laboratory confirmation, and genomic sequencing to trace origins, with prioritization processes like the CDC's One Health Zoonotic Disease Prioritization identifying high-risk pathogens such as avian influenza and rabies for focused monitoring. For instance, enhanced human surveillance during the 2014-2016 Ebola outbreak in West Africa incorporated real-time case reporting to detect clusters early, reducing secondary transmission. Peer-reviewed analyses highlight that combining human clinical data with animal morbidity reports improves predictive accuracy, as demonstrated in models for Nipah virus detection where early human case alerts prompted vector control. Contact tracing and isolation measures limit human-to-human spread following zoonotic introductions, particularly for pathogens with airborne or transmission. During the 2022 monkeypox outbreak, European health authorities implemented digital tools and manual tracing to identify and contacts, isolating over 80% of high-risk individuals within 72 hours in initial phases to curb exponential growth. Similarly, protocols for suspected exposures in the 2014 outbreak involved 21-day isolation periods, which, when rigorously enforced, contained localized chains of transmission. These strategies rely on rapid diagnostic testing and compliance, with from outbreak modeling showing that tracing efficiency above 80% can prevent widespread epidemics. Behavioral and preventive interventions target high-risk exposures, such as avoiding contact with wildlife or contaminated food sources. For vector-borne zoonoses like , public campaigns promote insect repellents and protective clothing, reducing incidence by up to 50% in affected U.S. populations during peak seasons. Food safety measures, including proper cooking of animal products, have averted outbreaks of from , with CDC guidelines emphasizing and hygiene to eliminate bacterial pathogens. Education initiatives, integrated into national plans, inform at-risk groups—such as hunters or veterinarians—about handwashing and barrier precautions, supported by data from longitudinal studies showing reduced seroprevalence in compliant communities. International cooperation enhances these strategies through data-sharing platforms like the WHO's Global Outbreak Alert and Response Network, which facilitated coordinated responses to the 2009 H1N1 swine flu pandemic by standardizing human surveillance protocols across borders. Travel restrictions and border screenings, applied judiciously, complement domestic efforts; for example, enhanced passenger screening during the 2015 Respiratory Syndrome () events in identified imported cases, preventing further zoonotic amplification. Despite biases in some institutional reporting toward overemphasizing environmental drivers, empirical outbreak data underscore that human behavioral adherence remains the decisive factor in containment success.

Vaccine Development and Therapeutics

Vaccine development for zoonotic diseases is complicated by the presence of animal reservoirs that sustain circulation, necessitating decisions on whether to prioritize , domestic animal, or vaccination to interrupt transmission chains. Antigenic drift and shift in viruses like , coupled with diversity in bacterial zoonoses such as species, hinder broad-spectrum efficacy, while unpredictable spillovers demand rapid platform technologies like mRNA or viral vectors. Veterinary vaccines have proven effective in reducing risk for diseases like , where canine immunization campaigns eliminated cases in regions achieving over 70% coverage by 2018. Established human vaccines include the inactivated rabies vaccine, routinely administered post-exposure since refinements in the 1980s, with efficacy exceeding 99% when given promptly alongside rabies immunoglobulin. The live-attenuated yellow fever vaccine, developed in 1937 and used in over 500 million doses by 2020, provides lifelong immunity in 99% of recipients against this mosquito-vectored flavivirus originating from primate reservoirs. For hemorrhagic fevers, the recombinant vesicular stomatitis virus-based Ebola vaccine (Ervebo) received FDA approval in 2019 following a 2014-2016 West African outbreak trial showing 97.5% efficacy in ring vaccination, though it targets only Zaire ebolavirus and requires cold-chain logistics. Emerging platforms, such as mRNA vaccines tested against Nipah and henipaviruses in preclinical models since 2020, aim to address high-fatality zoonoses from bat reservoirs but face hurdles in stability and human-animal cross-protection. Bacterial zoonoses like anthrax benefit from the anthrax vaccine adsorbed (AVA), a toxoid formulation protective against Bacillus anthracis inhalation strains, with post-exposure prophylaxis efficacy demonstrated in primate models at 92.5% when combined with antibiotics. Therapeutics for zoonotic infections often rely on supportive care and pathogen-specific agents, as many lack targeted options due to sporadic outbreaks limiting incentives. Bacterial zoonoses such as respond to combination antibiotics like plus rifampin for 6-8 weeks, achieving cure rates of 80-95% in uncomplicated cases, though chronic infections persist in 5-10% without control. For viral zoonoses, , an inhibitor, shortened recovery in patients by 4 days in the 2019 PALM trial (mortality 53.1% vs. 71.5% for standard care), but its broad use is tempered by variable efficacy against other filoviruses. Monoclonal antibodies like REGN-EB3 and mAb114 have shown superior survival rates (up to 90%) over in treatment during the 2018-2020 outbreaks, highlighting antibody-based therapies' potential for rapid deployment in high-containment settings. Parasitic zoonoses, such as , are managed with pyrimethamine-sulfadiazine regimens reducing congenital transmission risk from 60% to under 10% when initiated early in . Overall, therapeutics emphasize early and avoiding interventions that extend pathogen shedding, as seen in where prolonged use can increase aerosol transmission from livestock.

Controversies and Debates

Natural Spillover vs. Laboratory Origins

The debate over whether zoonotic diseases like emerge via natural spillover from animal reservoirs or through laboratory accidents has intensified since the , highlighting tensions between genomic analyses and circumstantial evidence of research activities. Natural spillover posits that jumped from to , possibly via an intermediate host at Wuhan's Huanan Seafood Market, supported by early case clustering near the market and genomic similarities to bat coronaviruses like , which shares 96% sequence identity. However, no intermediate host has been identified despite extensive sampling of animals at the market and networks, undermining claims of definitive zoonotic transfer. The virus's cleavage site, rare among sarbecoviruses and enabling efficient human transmission, has been cited as consistent with natural but also compatible with targeted , challenging early assertions of impossibility for lab manipulation. Proponents of a laboratory origin emphasize the Wuhan Institute of Virology's (WIV) extensive work on bat coronaviruses, including gain-of-function experiments funded partly by U.S. agencies through , which enhanced viral transmissibility in humanized models. WIV researchers conducted serial passaging of chimeric bat-human viruses under BSL-2 conditions, below international standards for high-risk pathogens, with reports of lab-acquired illnesses in autumn 2019 preceding the outbreak. U.S. intelligence assessments diverge: the FBI concluded with moderate confidence that a lab incident caused the , citing WIV's proximity to the outbreak epicenter and lapses, while the Department of Energy reached a similar low-confidence judgment; the CIA shifted in January 2025 to deeming a lab leak most likely, though with low confidence due to incomplete data. In contrast, four intelligence elements favor natural exposure, but the overall U.S. Intelligence Community notes both hypotheses remain plausible absent direct evidence. Critiques of natural-origin advocacy highlight potential biases, including the influential March 2020 "Proximal Origin" paper, which dismissed lab manipulation based on selective genomic interpretations but was privately doubted by its authors and revised to de-emphasize lab risks after editorial pressure. House investigations in December 2024 concluded a lab-related gain-of-function incident as the most probable origin, citing suppressed early lab-leak discussions and China's withholding of WIV data. WHO's 2025 advisory group report maintains zoonosis as likely but acknowledges unfinished investigations and calls for transparency, reflecting no . This impasse underscores zoonosis debates' reliance on incomplete epidemiological and virological data, with lab-origin hypotheses gaining traction from institutional research patterns rather than engineered bioweapon claims, which lack substantiation. Empirical resolution requires access to withheld sequences and samples, amid concerns over systemic underreporting of lab risks in .

Attribution to Climate Change and Habitat Loss

Habitat fragmentation and loss, primarily driven by deforestation and agricultural expansion, have been linked to elevated risks of zoonotic spillover by increasing human proximity to wildlife reservoirs and altering pathogen dynamics in animal populations. A 2021 review in Proceedings of the National Academy of Sciences analyzed over 1,400 studies and found that biodiversity loss, often resulting from habitat destruction, correlates with higher incidence of zoonotic pathogens, as degraded ecosystems facilitate denser host populations and novel host-pathogen interactions. For instance, in tropical regions like Southeast Asia and Central Africa, deforestation rates exceeding 10 million hectares annually between 2001 and 2020 have displaced bats and primates, leading to documented spillovers such as the Nipah virus in Malaysia in 1998–1999, where habitat encroachment intensified fruit bat contact with pigs and humans. Similarly, Ebola outbreaks in West Africa from 2013 to 2016 were associated with bushmeat hunting in deforested areas, where logging roads enabled deeper human penetration into primate habitats. Empirical evidence supports a causal pathway from loss to zoonoses through disrupted ecological barriers, but quantitative attribution remains challenging due to factors like . A study in and Infectious Disease highlighted rapid in the Amazon and Congo Basin as a key driver, with spillover events rising in parallel to a 20–30% loss of primary forest cover since 1990, though it emphasized that direct human-animal interfaces, rather than loss alone, precipitate transmission. Restoration efforts, such as , have shown potential to mitigate risks by buffering from human settlements, as evidenced by reduced vector-borne zoonoses in reforested European landscapes post-1950. However, some analyses caution that while habitat degradation amplifies exposure, it does not invariably cause outbreaks without additional amplifiers like intensified farming or markets. Attribution of zoonotic emergence to is more speculative and often relies on modeled projections rather than direct historical causation, with reviews indicating limited empirical support for widespread spillovers driven by warming alone. A 2023 systematic review of 218 studies found that only 32.7% concluded could "possibly" or "potentially" influence zoonotic systems, primarily through vector range expansions (e.g., ticks for ) or host migration, but lacked robust evidence for novel viral spillovers like coronaviruses. Temperature increases of 1–2°C since pre-industrial levels have shifted distributions northward, correlating with rising dengue cases (a zoonotic ) in since 2010, yet these patterns predate significant anthropogenic warming and align more closely with . Critics argue that media and policy narratives overstate climate's role, conflating it with land-use changes; a 2022 BioScience reviewed spillover events and found that while warming may exacerbate vector competence, primary drivers like habitat encroachment explain most variance, with climate effects often secondary or unproven. Debates persist over causal realism, as many zoonoses—such as HIV originating from chimpanzee hunts in the early 20th century—emerged during cooler climatic periods, suggesting anthropogenic behaviors outweigh climatic forcing. Projections from models, like those in a 2022 Nature study, predict up to 15,000 potential viral spillovers by 2070 under high-emissions scenarios due to bat range shifts, but these assume unverified host-switching probabilities and ignore adaptation. Peer-reviewed syntheses emphasize multifactorial risks, urging caution against attributing outbreaks solely to climate without disentangling from habitat loss or human density increases, which have risen 50% globally since 1950. This nuance counters alarmist claims, prioritizing verifiable interfaces over projected hazards.

Overstated Risks and Policy Implications

The assertion that zoonotic diseases pose an escalating threat has been challenged by analyses revealing that heightened outbreak reporting stems largely from advances in surveillance, diagnostics like PCR, and global data-sharing since the , rather than a true rise in natural spillover events. Comprehensive reviews of historical data show no sustained increase in zoonotic frequency or deadliness, with outbreak peaks in the and a post-2009 decline in reported incidence per global databases like , contradicting narratives from organizations such as the WHO and that invoke "epidemics every 4-5 years." For example, many cited events like Zika or exhibit mortality rates dwarfed by daily tuberculosis deaths (over 3,500), underscoring how low-impact outbreaks are amplified in messaging to emphasize novelty over comparative burden. A prominent case is the 2009 H1N1 swine flu pandemic, which triggered global alerts, border closures, and procurement of over 90 million doses in the UK alone, yet resulted in an estimated 150,000-575,000 excess deaths worldwide—milder than typical seasonal flu in vulnerability patterns and overall impact, with initial case counts later revised downward due to over-testing and diagnostic overreach. Public and expert critiques highlighted media sensationalism and premature "pandemic" declarations by the WHO, which fueled and wasted resources on unused stockpiles valued in billions across nations. These patterns of overstatement inform policy debates, where precautionary frameworks risk diverting substantial funds—such as the proposed $40 billion for global ""—from proven interventions against endemic killers like and , which claim millions of lives annually. Advocacy for sweeping "" surveillance and wildlife trade restrictions, often tied to unsubstantiated projections of accelerating spillovers, can impose economic costs on agriculture and biodiversity-dependent communities disproportionate to empirically demonstrated benefits, as evidenced by precautionary critiques warning that mitigation harms may exceed disease risks in low-probability scenarios. International instruments like the WHO's drafts have drawn scrutiny for embedding such assumptions into binding commitments, potentially eroding national over evidence-light zoonosis attributions while underemphasizing lab-related or other non-natural vectors.

References

  1. https://www.who.int/news-room/fact-sheets/detail/zoonoses
  2. https://www.ncbi.nlm.nih.gov/books/NBK596957/
  3. https://www.cdc.gov/one-health/about/about-zoonotic-diseases.html
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC5711306/
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC7563794/
  6. https://www.merckvetmanual.com/public-health/zoonoses/transmission-of-zoonoses-between-animals-and-humans
  7. https://www.ncbi.nlm.nih.gov/books/NBK570559/
  8. https://www.pnas.org/doi/10.1073/pnas.2023540118
  9. https://www.nature.com/articles/nrmicro.2017.45
  10. https://www.emro.who.int/about-who/rc61/zoonotic-diseases.html
  11. https://www.gao.gov/products/gao-23-105238
  12. https://harvardlawreview.org/print/vol-138/the-import-of-zoonotic-diseases/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC7149995/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC4921293/
  15. https://www.cdc.gov/one-health/about/index.html
  16. https://www.who.int/news-room/spotlight/influenza-are-we-ready/zoonotic-influenza
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC10406085/
  18. https://www.cdc.gov/dpdx/toxocariasis/index.html
  19. https://www.cdc.gov/parasites/causes/index.html
  20. https://www.cdc.gov/dpdx/az.html
  21. https://www.cdc.gov/healthy-pets/diseases/index.html
  22. https://my.clevelandclinic.org/health/diseases/zoonotic-diseases
  23. https://www.cdc.gov/brucellosis/hcp/animals/index.html
  24. https://www.who.int/news-room/fact-sheets/detail/rabies
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC10769134/
  26. https://www.ncbi.nlm.nih.gov/books/NBK448076/
  27. https://www.cdc.gov/rabies/php/protecting-public-health/index.html
  28. https://www.who.int/news-room/fact-sheets/detail/brucellosis
  29. https://www.cdc.gov/leptospirosis/about/index.html
  30. https://www.ncbi.nlm.nih.gov/books/NBK441858/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC4442676/
  32. https://www.cdc.gov/healthy-pets/about/dogs.html
  33. https://www.merckvetmanual.com/special-pet-topics/diseases-spread-between-animals-and-people-zoonoses/introduction-to-diseases-spread-between-animals-and-people-zoonoses
  34. https://www.science.org/doi/10.1126/science.abc2757
  35. https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases
  36. https://www.cdc.gov/west-nile-virus/data-maps/current-year-data.html
  37. https://www.ecdc.europa.eu/en/news-events/world-mosquito-day-2025-europe-sets-new-records-mosquito-borne-diseases
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC5610605/
  39. https://www.cdc.gov/ticks/data-research/facts-stats/tickborne-disease-surveillance-data-summary.html
  40. https://www.cdc.gov/ticks/about/index.html
  41. https://www.cdc.gov/food-safety/php/data-research/foodborne-illness-burden/index.html
  42. https://www.efsa.europa.eu/en/topics/topic/foodborne-zoonotic-diseases
  43. https://www.cdc.gov/food-safety/php/data-research/foodborne-illness-sources/index.html
  44. https://www.who.int/publications/i/item/9241562730
  45. https://pubmed.ncbi.nlm.nih.gov/26733222/
  46. https://www.epa.gov/sites/default/files/2019-03/documents/review-zoonotic-pathogens-waters.pdf
  47. https://www.who.int/health-topics/foodborne-diseases
  48. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6203a1.htm
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC5952368/
  50. https://pmc.ncbi.nlm.nih.gov/articles/PMC3323349/
  51. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5109a1.htm
  52. https://pubmed.ncbi.nlm.nih.gov/40872260/
  53. https://www.ncbi.nlm.nih.gov/books/NBK513243/
  54. https://wwwnc.cdc.gov/eid/article/23/11/17-0672_article
  55. https://www.cfsph.iastate.edu/Zoonoses_Textbook/Assets/zoonotic_diseases_by_routes_of_transmission_CA.pdf
  56. https://www.ecdc.europa.eu/en/q-fever/facts
  57. https://www.dir.ca.gov/title8/5199-1.html
  58. https://www.sciencedirect.com/science/article/pii/S254251962200064X
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC10215220/
  60. https://royalsocietypublishing.org/doi/10.1098/rstb.2016.0169
  61. https://www.aphis.usda.gov/livestock-poultry-disease/avian/avian-influenza/hpai-detections/commercial-backyard-flocks
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC7087879/
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC2857234/
  64. https://animal.law.harvard.edu/wp-content/uploads/Animal-Markets-and-Zoonotic-Disease-Risk-high-resolution.pdf
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC8182890/
  66. https://wwwnc.cdc.gov/eid/article/28/4/21-0249_article
  67. https://pmc.ncbi.nlm.nih.gov/articles/PMC8233965/
  68. https://royalsocietypublishing.org/doi/10.1098/rsos.211573
  69. https://link.springer.com/chapter/10.1007/978-3-031-68419-7_1
  70. https://www.mdpi.com/2078-1547/13/2/41
  71. https://pmc.ncbi.nlm.nih.gov/articles/PMC8092607/
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC3666729/
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC8776135/
  74. https://pmc.ncbi.nlm.nih.gov/articles/PMC11654033/
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC8573309/
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC8005368/
  77. https://www.cfr.org/report/global-governance-emerging-zoonotic-diseases
  78. https://pubmed.ncbi.nlm.nih.gov/37545541/
  79. https://www.who.int/activities/estimating-the-burden-of-foodborne-diseases
  80. https://pmc.ncbi.nlm.nih.gov/articles/PMC3415616/
  81. https://www.droracle.ai/articles/42850/what-is-the-estimated-global-cost-of-zoonotic-zoonosis-diseases-transmitted-from-animals-to-humans-diseases
  82. https://idpjournal.biomedcentral.com/articles/10.1186/s40249-024-01252-x
  83. https://www.who.int/initiatives/tripartite-zoonosis-guide/surveillance-and-information-sharing-operational-tool
  84. https://www.ncbi.nlm.nih.gov/books/NBK98092/
  85. https://wwwnc.cdc.gov/eid/article/18/12/12-0664_article
  86. https://www.sciencedirect.com/science/article/pii/S167492782300151X
  87. https://www.nature.com/articles/s41598-022-12619-1
  88. https://www.sciencedirect.com/science/article/pii/S2949704323000446
  89. https://www.ncbi.nlm.nih.gov/books/NBK215315/
  90. https://www.ncbi.nlm.nih.gov/books/NBK215319/
  91. https://nap.nationalacademies.org/read/10338/chapter/6
  92. https://www.cdc.gov/ncezid/topics-programs/global-health.html
  93. https://pmc.ncbi.nlm.nih.gov/articles/PMC10518360/
  94. https://www.news-medical.net/news/20240920/New-research-strengthens-the-case-for-a-zoonotic-origin-of-COVID-19.aspx
  95. https://www.science.org/doi/10.1126/science.abp8337
  96. https://www.who.int/news/item/27-06-2025-who-scientific-advisory-group-issues-report-on-origins-of-covid-19
  97. https://pmc.ncbi.nlm.nih.gov/articles/PMC12197743/
  98. https://www.who.int/emergencies/situations/mpox-outbreak
  99. https://www.cdc.gov/bird-flu/situation-summary/index.html
  100. https://www.cdc.gov/bird-flu/php/surveillance/chart-epi-curve-ah5n1.html
  101. https://www.nature.com/articles/s44298-025-00138-5
  102. https://wwwnc.cdc.gov/eid/article/30/4/24-0160_article
  103. https://globalbiodefense.com/2025/01/23/biodefense-headlines-23-january-2025/
  104. https://www.nature.com/articles/s41586-025-09192-8
  105. https://www.livescience.com/health/earliest-evidence-of-humans-catching-disease-from-animals-dates-to-6-500-years-ago
  106. https://www.smithsonianmag.com/smart-news/with-ancient-dna-scientists-have-mapped-37000-years-of-disease-across-europe-and-asia-180986964/
  107. https://www.tuckahoevet.com/post/a-history-of-rabies
  108. https://pmc.ncbi.nlm.nih.gov/articles/PMC7120709/
  109. https://journals.asm.org/doi/pdf/10.1128/microbiolspec.IOL5-0018-2015
  110. https://www.sciencedirect.com/science/article/abs/pii/S0736467903000799
  111. https://www.cdc.gov/one-health/about/one-health-history.html
  112. https://www.ncbi.nlm.nih.gov/books/NBK596959/
  113. https://pmc.ncbi.nlm.nih.gov/articles/PMC3323155/
  114. https://pmc.ncbi.nlm.nih.gov/articles/PMC7756848/
  115. https://www.nejm.org/doi/full/10.1056/NEJMra0904322
  116. https://www.pnas.org/doi/10.1073/pnas.1921186117
  117. https://pmc.ncbi.nlm.nih.gov/articles/PMC5777824/
  118. https://wwwnc.cdc.gov/eid/article/23/3/16-1285_article
  119. https://www.cdc.gov/ebola/outbreaks/index.html
  120. https://pmc.ncbi.nlm.nih.gov/articles/PMC10458268/
  121. https://www.nature.com/articles/s41579-021-00652-2
  122. https://emedicine.medscape.com/article/220967-overview
  123. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/rabies.html
  124. https://www.who.int/news-room/fact-sheets/detail/influenza-%28avian-and-other-zoonotic%29
  125. https://www.cdc.gov/flu-in-animals/about/index.html
  126. https://www.who.int/news-room/fact-sheets/detail/ebola-disease
  127. https://pmc.ncbi.nlm.nih.gov/articles/PMC7107455/
  128. https://www.nature.com/articles/s41467-021-21240-1
  129. https://pmc.ncbi.nlm.nih.gov/articles/PMC10994396/
  130. https://pmc.ncbi.nlm.nih.gov/articles/PMC1489021/
  131. https://www.tandfonline.com/doi/full/10.2217/hiv.10.33
  132. https://pmc.ncbi.nlm.nih.gov/articles/PMC4196475/
  133. https://pmc.ncbi.nlm.nih.gov/articles/PMC8223548/
  134. https://wwwnc.cdc.gov/eid/article/29/9/23-0052_article
  135. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/leptospirosis.html
  136. https://pmc.ncbi.nlm.nih.gov/articles/PMC11247264/
  137. https://www.who.int/news-room/fact-sheets/detail/plague
  138. https://www.cdc.gov/tularemia/about/index.html
  139. https://www.woah.org/en/disease/anthrax/
  140. https://www.who.int/news-room/fact-sheets/detail/campylobacter
  141. https://www.who.int/publications/i/item/9789241547130
  142. https://pmc.ncbi.nlm.nih.gov/articles/PMC4574773/
  143. https://www.mayoclinicproceedings.org/article/S0025-6196%2811%2960733-7/fulltext
  144. https://www.ncbi.nlm.nih.gov/books/NBK430905/
  145. https://www.cdc.gov/anthrax/about/index.html
  146. https://pmc.ncbi.nlm.nih.gov/articles/PMC9799061/
  147. https://www.ecdc.europa.eu/en/publications-data/leptospirosis-annual-epidemiological-report-2022
  148. https://www.cdc.gov/toxoplasmosis/about/index.html
  149. https://www.cdc.gov/toxoplasmosis/causes/index.html
  150. https://www.cdc.gov/dpdx/toxoplasmosis/index.html
  151. https://www.who.int/news-room/fact-sheets/detail/echinococcosis
  152. https://www.cdc.gov/dpdx/echinococcosis/index.html
  153. https://www.cdc.gov/dpdx/cysticercosis/index.html
  154. https://www.who.int/news-room/questions-and-answers/item/taeniasis-and-cysticercosis
  155. https://www.cdc.gov/trichinellosis/hcp/clinical-overview/index.html
  156. https://www.cdc.gov/trichinellosis/symptoms/index.html
  157. https://www.cdc.gov/variant-creutzfeldt-jakob/about/index.html
  158. https://www.cdc.gov/prions/about/index.html
  159. https://www.cdc.gov/fungal/ntds/index.html
  160. https://www.merckvetmanual.com/public-health/zoonoses/prevention-of-zoonoses
  161. https://pmc.ncbi.nlm.nih.gov/articles/PMC9319643/
  162. https://www.who.int/news/item/23-04-2019-increasing-the-adoption-of-animal-vaccines-to-address-livestock-losses-and-boost-control-of-neglected-zoonotic-diseases
  163. https://www.fao.org/animal-health/areas-of-work/biosecurity/en
  164. https://www.fao.org/4/a1140e/a1140e01.pdf
  165. https://www.cfsph.iastate.edu/Assets/tip-sheet-isolation-quarantine.pdf
  166. https://pmc.ncbi.nlm.nih.gov/articles/PMC10776649/
  167. https://www.sciencedirect.com/topics/medicine-and-dentistry/animal-culling
  168. https://globalizationandhealth.biomedcentral.com/articles/10.1186/s12992-023-00986-x
  169. https://www.nature.com/articles/s42003-020-1032-z
  170. https://www.who.int/news-room/fact-sheets/detail/one-health
  171. https://pmc.ncbi.nlm.nih.gov/articles/PMC5711328/
  172. https://www.cdc.gov/one-health/php/prioritization/index.html
  173. https://pmc.ncbi.nlm.nih.gov/articles/PMC11262259/
  174. https://pmc.ncbi.nlm.nih.gov/articles/PMC4916168/
  175. https://pmc.ncbi.nlm.nih.gov/articles/PMC7088161/
  176. https://www.ecdc.europa.eu/sites/default/files/documents/Considerations-for-Contact-Tracing-MPX_June%25202022.pdf
  177. https://www.ncbi.nlm.nih.gov/books/NBK596954/
  178. https://pmc.ncbi.nlm.nih.gov/articles/PMC10546628/
  179. https://pmc.ncbi.nlm.nih.gov/articles/PMC10460008/
  180. https://pmc.ncbi.nlm.nih.gov/articles/PMC9104671/
  181. https://www.mdpi.com/1999-4915/17/7/960
  182. https://pmc.ncbi.nlm.nih.gov/articles/PMC3170448/
  183. https://pmc.ncbi.nlm.nih.gov/articles/PMC7131227/
  184. https://pmc.ncbi.nlm.nih.gov/articles/PMC11946417/
  185. https://pubmed.ncbi.nlm.nih.gov/40733577/
  186. https://pmc.ncbi.nlm.nih.gov/articles/PMC3623508/
  187. https://www.merckvetmanual.com/public-health/zoonoses/treatment-of-zoonoses
  188. https://www.pnas.org/doi/10.1073/pnas.2214427119
  189. https://www.dni.gov/files/ODNI/documents/assessments/Unclassified-Summary-of-Assessment-on-COVID-19-Origins.pdf
  190. https://www.nature.com/articles/s41591-020-0820-9
  191. https://www.science.org/content/article/nih-says-grantee-failed-report-experiment-wuhan-created-bat-virus-made-mice-sicker
  192. https://2017-2021.state.gov/fact-sheet-activity-at-the-wuhan-institute-of-virology/
  193. https://www.cnn.com/2023/02/28/politics/wray-fbi-covid-origins-lab-china
  194. https://oversight.house.gov/release/wenstrup-releases-alarming-new-report-on-proximal-origin-authors-nih-suppression-of-the-covid-19-lab-leak-hypothesis/
  195. https://oversight.house.gov/release/final-report-covid-select-concludes-2-year-investigation-issues-500-page-final-report-on-lessons-learned-and-the-path-forward/
  196. https://pmc.ncbi.nlm.nih.gov/articles/PMC12040609/
  197. https://www.technologyreview.com/2021/06/29/1027290/gain-of-function-risky-bat-virus-engineering-links-america-to-wuhan/
  198. https://pmc.ncbi.nlm.nih.gov/articles/PMC8041730/
  199. https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2021.661063/full
  200. https://www.sciencedirect.com/science/article/abs/pii/S0095069621000346
  201. https://idpjournal.biomedcentral.com/articles/10.1186/s40249-023-01102-2
  202. https://www.nature.com/articles/s41558-022-01426-1
  203. https://academic.oup.com/bioscience/article/72/11/1099/6691424
  204. https://www.nature.com/articles/s41586-022-04788-w
  205. https://www.sciencedirect.com/science/article/pii/S0001706X21004034
  206. https://pmc.ncbi.nlm.nih.gov/articles/PMC12021773/
  207. https://onlinelibrary.wiley.com/doi/10.1111/1758-5899.13390
  208. https://pmc.ncbi.nlm.nih.gov/articles/PMC2988536/
  209. https://www.cbsnews.com/news/swine-flu-cases-overestimated/
  210. https://pmc.ncbi.nlm.nih.gov/articles/PMC3171979/
  211. https://academic.oup.com/phe/article/14/2/180/6283894
  212. https://www.publichealth.columbia.edu/news/hidden-hitchhikers-zoonoses-unscreened-wildlife-imports
  213. https://www.heritage.org/global-politics/report/the-who-pandemic-treaty-fails-again
Add your contribution
Related Hubs
User Avatar
No comments yet.